Immune system-wise, bleomycin ECT increases the infiltration of CD8+ T lymphocytes into the tumours by recruiting dendritic cells (DCs), while the presence of CD4+ T cells remains stable [41,42]. The gene discussed is CD8A; the disease is neoplasm.